Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation

Infectious Agents and Cancer

Research

Yinan Deng¹  Yewu Chen¹  Binsheng Fu¹  Xijian Zhang¹  Tong Zhang¹  Jianfeng Wang¹  Haobin Sun¹  Zhixing Liang¹  Shuhong Yi¹  Jianming Yang¹  Yang Yang² 

[1] Guangdong Provincial Key Laboratory of Liver Disease Research, Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China;Guangdong Provincial Key Laboratory of Liver Disease Research, Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China;Guangdong Provincial Key Laboratory of Liver Disease Research, Guangzhou, China;

关键词: Tenofovir disoproxil fumarate;    Entecavir;    Nucleos(t)ide analogues;    Hepatocellular carcinoma;    Recurrence;    Liver transplantation;   

DOI  :  10.1186/s13027-022-00478-4

 received in 2022-04-25, accepted in 2022-12-27,  发布年份 2022

来源: Springer

【 授权许可】

CC BY   
© The Author(s) 2023

【 图 表 】

Fig. 38

41116_2022_35_Article_IEq543.gif

Fig. 36